Industry litigation – Page 12
-
BusinessWashington state sues Monsanto over PCBs
Attorney general wants to recoup damages and cleanup costs related to polychlorinated biphenyls
-
Business£90m fine for Pfizer and Flynn Pharma over excessive drug pricing
Markets watchdog imposes record fine for breaches of competition law
-
BusinessChemical plant workers’ month-long strike
Momentive Performance Materials has drafted temporary contractors in dispute over benefits
-
BusinessFormer Valeant and Philidor executives arrested for fraud
Prosecutors allege the men masterminded a kickback scheme between Valeant and the speciality pharmacy
-
ReviewCrime scene to court: the essentials of forensic science (fourth edition)
Samantha Drake uncovers new truths in a revised text
-
BusinessCorn growers’ lawsuit contested by Syngenta
Syngenta opposes class action seeking over $5bn in damages related to its genetically engineered corn
-
NewsPfizer launches new biosimilar drug in US
Autoimmune disease treatment becomes only the second biosimilar to be approved by the FDA
-
BusinessTroubled Theranos abandons clinical testing
Seeking to salvage some value, once-admired blood analysis firm lays off 40% of staff
-
BusinessWest Virginia chemical leak was preventable
2014 spill that contaminated water supplies was caused by lack of proper tank inspections and repairs
-
BusinessUS senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
BusinessUS government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
BusinessRohm and Haas fined for safety violations
Fines relate to a trimethylaluminium explosion that injured four in January
-
BusinessFormer Lotte Chemical chief under fire
Ex-head of South Korean firm grilled by prosecutors over alleged fake accounting records
-
BusinessJuno CAR-T trial suspended after patient deaths
Immunotherapy study restarted with amended pre-treatment protocol
-
BusinessDuPont found liable in second of 3400 cancer cases
US jury awards over $5 million in claim linked to PFOA emitted by DuPont plant
-
BusinessBrexit uncertainty ripples across regulation
What might leaving the EU mean for medicines regulation, the Unified Patent Court, and the UK’s participation in Reach?
-
BusinessUnpicking doctor payments
Accepting even small meals from drug industry reps appears to influence doctors’ prescription rates
-
BusinessLies and deception see Astellas UK suspended by trade body
Company promoted drugs inappropriately and misled regulators in the resulting investigation
-
BusinessHarvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal